Chris Mallinson: gastroenterologist and pancreatic cancer researcher

“To our amazement, in which we were not alone, the regimen produced three to four months’ survival benefit in 40% of patients, and the trial opened the way to a more positive and now slightly more effective approach to inoperable pancreatic cancer,” he wrote in 2011. Jackson, who worked with him at...

Full description

Saved in:
Bibliographic Details
Published in:BMJ (Online) 2023-05, Vol.381, p.p1141
Main Author: Limb, Matt
Format: Article
Language:English
Subjects:
Chemotherapy
Communication
Endoscopy
Gastroenterology
Glucagon
Hospitals
Hypnotherapy
Obituaries
Pancreatic cancer
Physiology
Scholarships & fellowships
Tumors
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:“To our amazement, in which we were not alone, the regimen produced three to four months’ survival benefit in 40% of patients, and the trial opened the way to a more positive and now slightly more effective approach to inoperable pancreatic cancer,” he wrote in 2011. Jackson, who worked with him at Lewisham Hospital in the 1980s, recalls his fine organisational skills, quick wit, and enthusiasm. “The hospital was poorly equipped for modern gastroenterology, but Chris succeeded in raising enough money over a very short period to build a brand new and very well equipped endoscopy suite.”
ISSN:1756-1833
1756-1833
DOI:10.1136/bmj.p1141